KLRA Latest Press Releases

-- July 7, 2026 --

Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535 Globe Newswire 7:00 AM

-- June 29, 2026 --

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer Globe Newswire 7:30 AM

-- June 5, 2026 --

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026 Globe Newswire 7:32 PM

-- May 28, 2026 --

Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference Globe Newswire 4:05 PM

-- May 26, 2026 --

Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates Globe Newswire 4:02 PM

-- May 13, 2026 --

Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions Globe Newswire 7:30 AM

-- April 22, 2026 --

Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth PRNewswire 5:40 AM

-- April 20, 2026 --

Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software